This website uses technical, customisation and analytical cookies, both first-party and third-party, to anonymously facilitate browsing and analyse statistics on use of the website. Learn more
Search results
-
Soomaa Labs OU (C)
Johnson, Rob; Kolarova, LenkaCase E-220-EEntrepreneurship, FinanceThe fast-growing company in this case is considering pursuing an IPO on NASDAQ. The A case focuses on whether the company should do the IPO and, if so, what the process would involve and what the IPO valuation might be. The B case examines proposals from four investment banks to be the lead advisor on the IPO. The C case describes events leading up to the final stages just prior to the IPO.Starting at €5.74
-
Soomaa Labs OU (B)
Johnson, Rob; Kolarova, LenkaCase E-219-EEntrepreneurship, FinanceThe fast-growing company in this case is considering pursuing an IPO on NASDAQ. The A case focuses on whether the company should do the IPO and, if so, what the process would involve and what the IPO valuation might be. The B case examines proposals from four investment banks to be the lead advisor on the IPO. The C case describes events leading up to the final stages just prior to the IPO.Starting at €5.74
-
Soomaa Labs OU (A)
Johnson, Rob; Kolarova, LenkaCase E-218-EEntrepreneurship, FinanceThe fast-growing company in this case is considering pursuing an IPO on NASDAQ. The A case focuses on whether the company should do the IPO and, if so, what the process would involve and what the IPO valuation might be. The B case examines proposals from four investment banks to be the lead advisor on the IPO. The C case describes events leading up to the final stages just prior to the IPO.Starting at €8.20
-
Genmedi: How to Value a New Company for an Upcoming Round of Financing
Liechtenstein, Heinrich; Kolarova, LenkaCase E-207-EEntrepreneurship, FinanceEvery venture capital and private equity deal involves determining the value of the company. This is one of the most important-and most difficult-tasks faced by an investor (and an entrepreneur), and skill is required when using the various methods for valuing a company. In March 2019, the investors in LifeCycle Ltd.-a technology company based in Shanghai, China-set up a new company, Genmed, to capitalize on an innovative technology for biologica...Starting at €8.20